Abbott Laboratories

Open: 108.86 Close: 109.03 Change: 0.17

The top 14 things about Abbott Laboratories Company Inc Stock found by an AI.

Are looking for the most relevant information about Abbott Laboratories? Investor spend a lot of time searching for information to make investment decisions in Abbott Laboratories. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Abbott Laboratories are: Abbott, Laboratories, Risks, Shareholder, trading, day, Returns, and the most common words in the summary are: abbott, stock, job, laboratory, market, price, news, . One of the sentences in the summary was: Shares of Abbott Laboratories inched 051% higher to $109.03 on Friday.. …

Concept Map

Semantic Network

Stock Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products. The company operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Diagnostic segment offers laboratory systems in the.

Today's Summary

Abbott Laboratories is one of the Safest Dividend Growth Stocks On The Market. Shares of Abbott Laboratories inched 051% higher to $109.03 on Friday.

Today's News

Risks To Shareholder Returns Are Elevated At These Prices For Abbott Laboratories (NYSE:ABT) Risks to Shareholder returns are elevated at these prices for abbott laboratories (nyse:abt). Abbott Laboratories is one of the Safest Dividend Growth Stocks On The Market. Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. Abbott Laboratories reachead $108.42 at the closing of the latest trading day, reflecting a +0.33% change compared to its last close. Abbott Laboratories announced earnings per share of $1.14 for the fiscal quarter ending 2023-09-30 , beating the average analyst estimate. Abbott Laboratories stock outperforms market on strong trading day. Shares of Abbott Laboratories inched 051% higher to $109.03 on Friday. Abbott Laboratories to go ex-dividend on January 11th, 2024.

Stock Profile

"Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois."

Keywords

The game is changing. There is a new strategy to evaluate Abbott Laboratories fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Abbott Laboratories are: Abbott, Laboratories, Risks, Shareholder, trading, day, Returns, and the most common words in the summary are: abbott, stock, job, laboratory, market, price, news, . One of the sentences in the summary was: Shares of Abbott Laboratories inched 051% higher to $109.03 on Friday.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbott #stock #job #laboratory #market #price #news.